Renaissance Capital has updated the 2018 US IPO Annual Review with returns through December 31. Download a free Preview of the report, and sign up for IPO market updates delivered to your...read more
In terms of proceeds and deal flow, 2018 has been a standout year in the IPO market. The year's 185 IPOs have raised almost $45 billion, more than 20% higher than this time last year on both counts. The billion-dollar unicorn club featured well-known...read more
Six IPOs raised $2.9 billion this week. Four traded up over 40%, and none finished the week below issue. Spun out of Eli Lilly, Elanco Animal Health (ELAN) priced above its range to raise $1.5 billion. The company popped 50% on its...read more
Eventbrite, an online live event ticketing platform, raised $230 million by offering 10 million shares at $23, the high end of the revised range of $21 to $23. The company originally filed with a proposed range of $19 to $21, before increasing it on Tuesday.
...read more
Renaissance Capital's Updated 2018 US IPO Annual Review
Renaissance Capital has updated the 2018 US IPO Annual Review with returns through December 31. Download a free Preview of the report, and sign up for IPO market updates delivered to your...read more
Renaissance Capital's shortlist of the 10 biggest names targeting 2019 IPOs
In terms of proceeds and deal flow, 2018 has been a standout year in the IPO market. The year's 185 IPOs have raised almost $45 billion, more than 20% higher than this time last year on both counts. The billion-dollar unicorn club featured well-known...read more
US IPO Weekly Recap: 4 IPOs pop 40% including Eventbrite, Farfetch and Elanco
Six IPOs raised $2.9 billion this week. Four traded up over 40%, and none finished the week below issue. Spun out of Eli Lilly, Elanco Animal Health (ELAN) priced above its range to raise $1.5 billion. The company popped 50% on its...read more
That's the ticket! Eventbrite prices IPO at $23 high end
Eventbrite, an online live event ticketing platform, raised $230 million by offering 10 million shares at $23, the high end of the revised range of $21 to $23. The company originally filed with a proposed range of $19 to $21, before increasing it on Tuesday. ...read more